图片.png For research use only

Product Infomation
Product NameBetaxolol
CAS No.

63659-18-7

Molecular Weight

307.43

Formula

C₁₈H₂₉NO₃

SMILES

OC(CNC(C)C)COC1=CC=C(CCOCC2CC2)C=C1

Stock statusGet quote



Online consultation: s_qq.png  s_email.png



Product description

Description

                           

Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma. Target: Beta1 Adrenergic Receptor Betaxolol is a cardioselective beta-adrenergic receptor blocking agent. Betaxolol (5 mg/kg via i.p. injection) was administered at 24 and then 44 h following the final chronic cocaine administration. Animals treated with betaxolol during cocaine withdrawal exhibited a significant attenuation of anxiety-like behavior characterized by increased time spent in the open arms and increased entries into the open arms compared to animals treated with only saline during cocaine withdrawal. Betaxolol did not produce anxiolytic-like effects in control animals treated chronically with saline [1]. Betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol. Betaxolol may be relatively safer to use in patients with reactive airway disease than either timolol or levobunolol [2].


IC50 & Target

________________________________________________________________________________________


In Vitro

_________________________________________________________________________________________






Powder-20°C3 years

4°C2 years
In solvent-80°C6 months

-20°C1 month







Peferences:

[1]. Rudoy, C.A. and E.J. Van Bockstaele, Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5): p. 1119-29.

[2]. Lesar, T.S., Comparison of ophthalmic beta-blocking agents. Clin Pharm, 1987. 6(6): p. 451-63.